SNYR

Synergy CHC Corp.
—

Company Information

Company Name
Synergy CHC Corp.
CIK
CIK0001562733
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
SNYR: Nasdaq
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2833
SIC Description
Medicinal Chemicals & Botanical Products
Ticker
SNYR

SEC filing data through

Insider Sentiment

Last purchase
2025-07-30
Last sale
—
Shares purchased (TTM)
302,400
Shares sold (TTM)
0
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
536,856
Shares outstanding
11,303,853
Ownership
4.75%
-0.04% Y/Y

Earnings Market Reaction

Filing date
2026-05-14
Price on filing date
—
1-month reaction
-24.00%
3-month reaction
-36.00%
Drift continued2/6 (33%)
Faded / reversed4/6 (67%)

Balance Sheet

Values in millions ($)
Line item2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value0311010
Restricted Cash Current0000000
Accounts Receivable Net Current1377454
Assets Current
Assets Current6102120151612
Other Receivables Net Current--2222-
Prepaid Expense Current1042221
Inventory Net3422222
Intangible Assets Net Excluding Goodwill0000000
Assets6102120161612
Liabilities And Stockholders Equity
Accounts Payable And Accrued Liabilities Current4645355
Taxes Payable Current0000000
Liabilities Current
Liabilities Current784781718
Contract With Customer Liability Current-000000
Short Term Borrowings---258-
Long Term Debt Current-----47
Notes Payable Current32-----
Operating Lease Liability Noncurrent-----8-
Liabilities Noncurrent
Liabilities Noncurrent25252525231619
Long Term Notes Payable2525252511710
Liabilities32332932313337
Common Stock Value0000000
Additional Paid In Capital Common Stock34343430282819
Stockholders Equity
Stockholders Equity-25-23-8-12-16-17-25
Accumulated Other Comprehensive Income Loss Net Of Tax-0-0-0-0-0-00
Retained Earnings Accumulated Deficit-59-56-42-42-43-44-44
Treasury Stock Value-0-0-0-0-0-0-
Liabilities And Stockholders Equity6102120161612
Related Party10-00444
Accounts Payable And Other Accrued Liabilities Current0000-0-
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.00
Common Stock Shares Authorized300300300300300300300
Common Stock Shares Issued11111110998
Shares Outstanding1111119998
Treasury Stock Common Value-----0-
Treasury Stock Common Shares000000-

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Synergy CHC Corp. (SNYR) — SEC Financial Statements & Analysis

Synergy CHC Corp. (SNYR) is a medicinal chemicals & botanical products company, incorporated in NV. Synergy CHC Corp. trades on Nasdaq as: SNYR. Synergy CHC Corp. (SNYR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-14. Based on that filing, On profitability, Synergy CHC Corp. posts a gross margin of 65.37%, an operating margin of -39.61%, a net margin of -56.98%, a Return on Equity (ROE) of 76.92%, a Return on Assets (ROA) of -142.75%, and a Return on Invested Capital (ROIC) of -931.71%. Per share, it reports EPS of $-1.40, diluted EPS of $-1.40, free cash flow per share of $-0.34, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -43.60% year-over-year, net income growth of -583.72% year-over-year, and EPS growth of -466.33% year-over-year. On the balance sheet, it maintains a current ratio of 0.93x, a quick ratio of 0.24x, working capital of $-503.86K, a debt-to-equity ratio of -1.25x, a debt ratio of 4.93, an interest coverage ratio of -1.61x, free cash flow of $-3.81M (TTM), and net debt of $27.36M. Figures sourced from SEC EDGAR.

EPS TTM
$-1.40
ROE TTM
76.92%
ROA TTM
-142.75%
Debt To Equity
-1.25x
Free Cash Flow TTM
$-3.81M
Net Revenue TTM Growth 1Y
-43.60%

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Synergy CHC Corp. in?

Synergy CHC Corp. (SNYR) operates in the Medicinal Chemicals & Botanical Products industry.

What exchange does SNYR trade on?

Synergy CHC Corp. (SNYR) trades on the Nasdaq.

Where is Synergy CHC Corp. incorporated?

Synergy CHC Corp. is incorporated in NV.

When was Synergy CHC Corp. (SNYR)'s most recent SEC filing?

Synergy CHC Corp. (SNYR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-14.

What is SNYR's EPS (earnings per share)?

Synergy CHC Corp. (SNYR)'s trailing twelve month EPS is $-1.40 as of 2026-03-31.

What is SNYR's ROE (return on equity)?

Synergy CHC Corp. (SNYR)'s trailing twelve month Return on Equity (ROE) is 76.92% as of 2026-03-31.

What is SNYR's ROA (return on assets)?

Synergy CHC Corp. (SNYR)'s trailing twelve month Return on Assets (ROA) is -142.75% as of 2026-03-31.

What is SNYR's ROIC (return on invested capital)?

Synergy CHC Corp. (SNYR)'s trailing twelve month Return on Invested Capital (ROIC) is -931.71% as of 2026-03-31.

Wall Street's data.
Main Street's price.